By Fineline Cube 
China-based Ningbo Jansen NMR Technology Co., Ltd. announced that its initial public offering (IPO) filing with the Shanghai Stock Exchange’s Sci-Tech Innovation Board (STAR) has been accepted for review. The company expects to raise RMB 865 million (USD 120 million), with GF Securities serving as the sponsor.
Company Focus
Jansen Superconducting specializes in manufacturing core components for MRI equipment, including 1.5T zero-boil-off and 1.5T liquid-helium-free superconducting magnets, which are already in mass production.
Funding Allocation
The proceeds from the IPO will be used to support projects such as the annual production of 600 sets of helium-free superconducting magnets and to supplement working capital. This funding will further enhance the company’s technological capabilities and market position in the MRI equipment sector.-Fineline Info & Tech